Filter
844
Filtered Results: 844
Text search:
Krebs
Featured
Recommendations
70
New Publications
121
Language
Document type
Studies & Reports
242
No document type
238
Guidelines
162
Fact sheets
56
Manuals
41
Strategic & Response Plan
29
Brochures
21
Resource Platforms
16
Training Material
11
Dashboards/Maps
9
Situation Updates
6
Infographics
6
Videos
5
Online Courses
2
Countries / Regions
Germany
149
Global
75
Africa
23
India
22
Kenya
21
South Africa
16
Latin America and the Carribbean
14
Tanzania
8
North America
8
Ukraine
7
Western and Central Europe
7
Ethiopia
7
Indonesia
7
Malawi
6
Nepal
4
Sierra Leone
4
Chile
4
Congo, Democratic Republic of
4
Argentina
4
Brazil
4
Russia
4
Thailand
3
Ghana
3
Cameroon
3
Senegal
3
Burkina Faso
3
Peru
3
Zimbabwe
3
Philippines
3
Mozambique
3
Venezuela
3
Middle East and North Africa
3
South–East Asia Region
3
Paraguay
3
Uganda
3
Switzerland
2
Nigeria
2
Guinea-Bissau
2
West and Central Africa
2
Gabon
2
France
2
Bangladesh
2
Eastern Europe
2
Angola
2
Zambia
2
Pakistan
2
Colombia
1
Mexico
1
Lesotho
1
China
1
Rwanda
1
Iran
1
Laos
1
Morocco
1
Asia
1
Jordan
1
Saudi Arabia
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Turkmenistan
1
Maldives
1
Mauritius
1
United Kingdom
1
Spain
1
East and Southern Africa
1
Bolivia
1
Vietnam
1
Papua New Guinea
1
Sri Lanka
1
Mali
1
Libya
1
South Sudan
1
Iraq
1
Ecuador
1
Eswatini/ Swaziland
1
Bahamas
1
Authors & Publishers
Publication Years
Category
Countries
186
Clinical Guidelines
128
Public Health
121
Women & Child Health
25
Capacity Building
24
Key Resources
18
Pharmacy & Technologies
5
Toolboxes
NCDs
209
Refugee
146
AMR
146
COVID-19
51
Global Health Education
31
Caregiver
29
Mental Health
27
Planetary Health
18
TB
14
Pharmacy
13
Rapid Response
10
Disability
10
Conflict
8
HIV
7
Ebola & Marburg
5
Social Ethics
3
NTDs
3
Natural Hazards
2
Specific Hazards
1
Cholera
1
Health Financing Toolbox
1
Zika
1
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in the Region of the Americas and projections show its prevalence will continue rising over the following years. The...
Monitoring is a crucial element in any successful programme. It is important to
know if health care facilities – and ultimately countries – are meeting the agreed
goals and objectives for preventing and managing cardiovascular diseases (CVD).
Monitoring is the on-going collection, management ...
In 2014, the World Heart Federation (WHF) launched
an initiative to develop a series of Roadmaps [1e6]. Their
aim is to identify potential roadblocks on the pathway to
effective prevention, detection, and management of cardiovascular disease (CVD), along with evidence-based
solutions to overcome...
Non-communicable diseases (NCDs) pose a substantial threat to many health systems, especially in low-income and middle-income countries (LMICs) where they are already overstretched. In the past few decades, deaths from NCDs in LMICs have spiked, whereas numbers in high-income countries have stabilis...
Cardiovascular disease (CVD) describes a group of conditions that affect your heart or blood vessels. Cardiovascular events like heart attacks and strokes are very serious.
CVDs are the number 1 cause of death globally: more people die annually from CVDs than from any other cauAn estimated 17.5 m
Global cardiovascular disease (CVD) burden is high and rising, especially in low-income and middle-income countries (LMICs). Focussing on 45 LMICs, we aimed to determine (1) the adult population’s median 10-year predicted CVD risk, including its variation within countries by socio-demographic char...
Cardiovascular disease (CVD) is a general term for conditions affecting the heart or blood vessels.
It's usually associated with a build-up of fatty deposits inside the arteries (atherosclerosis) and an increased risk of blood clots.
It can also be associated with damage to arteries in organs such...
Procurement and supply management activities are fundamental to consistent and reliable access to essential medicines and health products. To reduce the impact of CVD, action needs to be taken to improve prevention, diagnosis, care and management of CVD diseases. Affordable essential medicines and t...
In many low- and middle-income countries, there is a wide gap between evidencebased recommendations and current practice. Treatment of major CVD risk factors remains suboptimal, and only a minority of patients who are treated reach their target levels for blood pressure, blood sugar and blood choles...
Various videos on different topics in different languages.
The website provides information on cardiovascular diseases (key facts, definitions, risk factors etc.).
Cardiovascular disease (CVD) is the leading cause of global deaths, with the majority occurring in low- and middle-income countries (LMIC). The primary and secondary prevention of CVD is suboptimal throughout the world, but the evidence-practice gaps are much more pronounced in LMIC. Barriers at the...
Development of cardiovascular disease (CVD) is influenced by risk factors such as:
tobacco use, an unhealthy diet, physical inactivity, obesity (which can result from
a combination of unhealthy diet, physical inactivity, and other factors), elevated
blood pressure (hypertension), abnormal blood l...
HEARTS provides a set of locally adaptable tools for strengthening the
management of CVD in primary health care.
HEARTS is designed to enhance implementation of WHO PEN by providing:
• operational guidance on further integrating CVD management
• technical guidance on evaluating the impact of...
The Cardiovascular Journal of Africa (CVJA) is an international peer-reviewed journal that keeps cardiologists up to date with advances in the diagnosis and treatment of cardiovascular disease. Topics covered include coronary disease, electrophysiology, valve disease, imaging techniques, congenital ...
Background
In the prevention of cardiovascular disease, a WHO target is that at least 50% of eligible people use statins. Robust evidence is needed to monitor progress towards this target in low-income and middle-income countries (LMICs), where most cardiovascular disease deaths occur. The objectiv...
The pharmacological treatment of heart failure has evolved over the last three decades since the demonstration of the effect of angiotensinconverting enzyme inhibitors on major cardiovascular events in patients with heart failure with reduced ejection fraction. Composite analysis of heart failure wi...
Cardiovascular disease (CVD), also called heart and circulatory disease, is an umbrella name for conditions that affect your heart or circulation. These include high blood pressure, stroke and vascular dementia.
The World Health Organization (WHO) released its first-ever report on the devastating global impact of high blood pressure, along with recommendations on the ways to win the race against this silent killer. The report shows approximately 4 out of every 5 people with hypertension are not adequately t...
